Cartilage Repair Market Size, Share, Growth Analysis, By Treatment Modality(Cell-based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-cell-based (Tissue Scaffolds), By Application(Knee, Hip, Ankle and Foot, and Other Application Sites), By Application site(Hyaline Cartilage, Fibrocartilage), By Region - Industry Forecast 2024-2031

Global Cartilage Repair Market size was valued at around USD 1 billion in 2022 and is expected to rise from USD 1.25 billion in 2023 to reach a value of USD 4.38 billion by 2031, at a CAGR of 17% over the forecast period (2024–2031).

The global cartilage repair market is fragmented, with a prominent market player acquiring a sizable portion. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective. 'DePuy Synthes (Johnson & Johnson) ', 'Zimmer Biomet Holdings Inc. ', 'Smith & Nephew plc ', 'Vericel Corporation ', 'Osiris Therapeutics Inc. ', 'Histogenics Corporation ', 'Anika Therapeutics Inc ', 'Arthrex Inc. ', 'B. Braun Melsungen AG ', 'Stryker Corporation ', 'CONMED Corporation ', 'Orthocell Limited ', 'RTI Surgical Holdings Inc. ', 'MEDIPOST Co. Ltd. ', 'CellGenix GmbH ', 'Tissue Regenix Group plc ', 'CollPlant Biotechnologies Ltd. ', 'ISTO Technologies Inc. ', 'MTF Biologics ', 'CartiHeal Ltd.'

Osteoarthritis has become increasingly common in recent years throughout the world. According to a University of North Carolina study, approximately 1 million knee and hip replacement procedures are performed in the United States each year. The annual cost of osteoarthritis in the United States is $136.8 billion. According to the Arthritis Foundation, degenerative joint diseases such as osteoarthritis will affect more than 130 million people worldwide by 2050. Two of the most common treatments for osteoarthritis are autologous chondrocyte implantation and Scaffolds implants. As a result, as the prevalence of osteoarthritis rises, so will demand for cartilage repair and regeneration products.

The number of companies focusing on the development of cartilage regeneration products has increased significantly in recent years as a result of rising government investments in regenerative medicine for cartilage regeneration research. As a result of these factors, the number of clinical trials and the development of new cartilage regeneration technologies has increased. Major market players are investing heavily in R&D, resulting in a robust pipeline of products based on various approaches to cartilage repair.

Based on region global cartilage repair market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East Africa. The Asia Pacific region is expected to grow at a faster rate. North America accounted for the largest share of the cartilage repair and regeneration market, owing to the high prevalence of osteoarthritis, the growing prevalence of sports injuries, and increased research funding in the United States and Canada. In addition, increased physician and patient awareness of innovative treatment techniques and technologies, as well as significant government investments in Cartilage Repair/Regeneration technologies and therapies, are all contributing to the market's growth in North America. Over the projection period, the Asia Pacific region is expected to grow at a faster rate than other regions. Furthermore, the increased prevalence of osteoporosis in Australia and New Zealand is leading to an increase in cartilage injury, which is expected to accelerate vertical growth. South American, Middle Eastern, and African (MEA) markets have been gradually expanding in recent years. Because of the large population suffering from chronic joint and bone problems, these markets have untapped potential.